GeoVax Labs, Inc. (GOVX)
USD 1.02
(7.31%)
USD 1.02
(7.31%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -20.72 Million USD | -83935.43% |
| 2022 | 24.71 Thousand USD | 100.16% |
| 2021 | -15.16 Million USD | -2340.9% |
| 2020 | -621.45 Thousand USD | 15.43% |
| 2019 | -734.81 Thousand USD | 19.75% |
| 2018 | -915.65 Thousand USD | 2.81% |
| 2017 | -942.08 Thousand USD | 17.5% |
| 2016 | -1.14 Million USD | 9.73% |
| 2015 | -1.26 Million USD | -36.02% |
| 2014 | -930.01 Thousand USD | -87.0% |
| 2013 | -497.32 Thousand USD | -28.67% |
| 2012 | -386.52 Thousand USD | -107.89% |
| 2011 | 4.89 Million USD | -5.5% |
| 2010 | 5.18 Million USD | 41.36% |
| 2009 | 3.66 Million USD | 26.05% |
| 2008 | 2.91 Million USD | 1127.9% |
| 2007 | 237 Thousand USD | -72.21% |
| 2006 | 852.9 Thousand USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 180.23 Thousand USD | 244.43% |
| 2001 | -124.79 Thousand USD | 93.81% |
| 2000 | -2.01 Million USD | 21.09% |
| 1999 | -2.55 Million USD | -554.38% |
| 1998 | -390.37 Thousand USD | 75.83% |
| 1997 | -1.61 Million USD | -771.78% |
| 1996 | -185.28 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -19.57 Thousand USD | -123.96% |
| 2024 Q2 | 276.93 Thousand USD | -20211.56% |
| 2023 Q1 | -17.31 Thousand USD | 89.38% |
| 2023 FY | -74.16 Thousand USD | -400.08% |
| 2023 Q4 | 81.69 Thousand USD | 571.73% |
| 2023 Q3 | -17.31 Thousand USD | -0.01% |
| 2023 Q2 | -17.31 Thousand USD | 0.01% |
| 2022 Q4 | -163.05 Thousand USD | -822.5% |
| 2022 FY | 24.71 Thousand USD | 100.16% |
| 2022 Q1 | 69.25 Thousand USD | -57.89% |
| 2022 Q3 | -17.67 Thousand USD | -44.06% |
| 2022 Q2 | -12.26 Thousand USD | -117.72% |
| 2021 Q3 | -1.19 Million USD | -58.53% |
| 2021 Q4 | 164.46 Thousand USD | 113.77% |
| 2021 FY | -15.16 Million USD | -2340.9% |
| 2021 Q1 | -492.36 Thousand USD | 2.64% |
| 2021 Q2 | -753.12 Thousand USD | -52.96% |
| 2020 Q4 | -505.72 Thousand USD | -38861.86% |
| 2020 Q3 | -1298.00 USD | 93.77% |
| 2020 Q2 | -20.81 Thousand USD | 77.6% |
| 2020 Q1 | -92.95 Thousand USD | 44.53% |
| 2020 FY | -621.45 Thousand USD | 15.43% |
| 2019 FY | -734.81 Thousand USD | 19.75% |
| 2019 Q4 | -167.58 Thousand USD | -24.63% |
| 2019 Q1 | -191.48 Thousand USD | -17.86% |
| 2019 Q2 | -241.28 Thousand USD | -26.01% |
| 2019 Q3 | -134.46 Thousand USD | 44.27% |
| 2018 Q3 | -208.35 Thousand USD | 25.3% |
| 2018 Q2 | -278.93 Thousand USD | -4.98% |
| 2018 Q1 | -265.69 Thousand USD | 1.54% |
| 2018 Q4 | -162.46 Thousand USD | 22.02% |
| 2018 FY | -915.65 Thousand USD | 2.81% |
| 2017 Q2 | -166.09 Thousand USD | 35.07% |
| 2017 FY | -942.08 Thousand USD | 17.5% |
| 2017 Q1 | -255.79 Thousand USD | 7.46% |
| 2017 Q4 | -269.85 Thousand USD | -7.85% |
| 2017 Q3 | -250.2 Thousand USD | -50.64% |
| 2016 Q2 | -231.29 Thousand USD | 40.69% |
| 2016 Q1 | -390 Thousand USD | -6.49% |
| 2016 Q4 | -276.4 Thousand USD | -13.36% |
| 2016 FY | -1.14 Million USD | 9.73% |
| 2016 Q3 | -243.83 Thousand USD | -5.42% |
| 2015 Q4 | -366.24 Thousand USD | -28.27% |
| 2015 FY | -1.26 Million USD | -36.02% |
| 2015 Q2 | -313.17 Thousand USD | -4.32% |
| 2015 Q1 | -300.2 Thousand USD | -22.37% |
| 2015 Q3 | -285.52 Thousand USD | 8.83% |
| 2014 FY | -930.01 Thousand USD | -87.0% |
| 2014 Q4 | -245.32 Thousand USD | -137.23% |
| 2014 Q3 | -103.41 Thousand USD | 69.2% |
| 2014 Q2 | -335.76 Thousand USD | -36.76% |
| 2014 Q1 | -245.52 Thousand USD | 42.35% |
| 2013 Q3 | 125.1 Thousand USD | 212.06% |
| 2013 Q4 | -425.84 Thousand USD | -440.39% |
| 2013 FY | -497.32 Thousand USD | -28.67% |
| 2013 Q1 | -84.94 Thousand USD | 56.99% |
| 2013 Q2 | -111.63 Thousand USD | -31.42% |
| 2012 Q1 | 854.06 Thousand USD | -10.74% |
| 2012 FY | -386.52 Thousand USD | -107.89% |
| 2012 Q4 | -197.49 Thousand USD | -643.92% |
| 2012 Q2 | 705.69 Thousand USD | -17.37% |
| 2012 Q3 | 36.31 Thousand USD | -94.85% |
| 2011 FY | 4.89 Million USD | -5.5% |
| 2011 Q3 | 1.29 Million USD | -26.01% |
| 2011 Q2 | 1.75 Million USD | 96.31% |
| 2011 Q1 | 893 Thousand USD | -5.63% |
| 2011 Q4 | 956.84 Thousand USD | -26.23% |
| 2010 Q3 | 1.16 Million USD | -33.04% |
| 2010 FY | 5.18 Million USD | 41.36% |
| 2010 Q4 | 946.24 Thousand USD | -18.66% |
| 2010 Q1 | 1.33 Million USD | 237.43% |
| 2010 Q2 | 1.73 Million USD | 29.78% |
| 2009 Q3 | 1.8 Million USD | 140.24% |
| 2009 Q4 | 396.68 Thousand USD | -78.07% |
| 2009 FY | 3.66 Million USD | 26.05% |
| 2009 Q1 | 710.15 Thousand USD | 16.11% |
| 2009 Q2 | 752.8 Thousand USD | 6.01% |
| 2008 Q4 | 611.59 Thousand USD | -53.75% |
| 2008 Q3 | 1.32 Million USD | 251.66% |
| 2008 Q2 | 376.07 Thousand USD | -37.32% |
| 2008 Q1 | 599.99 Thousand USD | 0.0% |
| 2008 FY | 2.91 Million USD | 1127.9% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 FY | 237 Thousand USD | -72.21% |
| 2007 Q4 | - USD | 0.0% |
| 2006 FY | 852.9 Thousand USD | 0.0% |
| 2006 Q4 | 374.05 Thousand USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2002 Q1 | -351.94 Thousand USD | 2.07% |
| 2002 Q2 | 16.31 Thousand USD | 104.64% |
| 2002 FY | 180.23 Thousand USD | 244.43% |
| 2002 Q4 | -272.27 Thousand USD | -337.35% |
| 2002 Q3 | 114.71 Thousand USD | 603.09% |
| 2001 Q3 | 50.73 Thousand USD | -24.58% |
| 2001 Q2 | 67.27 Thousand USD | -42.29% |
| 2001 FY | -124.79 Thousand USD | 93.81% |
| 2001 Q1 | 116.56 Thousand USD | 106.02% |
| 2001 Q4 | -359.37 Thousand USD | -808.3% |
| 2000 FY | -2.01 Million USD | 21.09% |
| 2000 Q4 | -1.93 Million USD | -7077.93% |
| 2000 Q3 | 27.74 Thousand USD | 108.01% |
| 2000 Q2 | -346.25 Thousand USD | -50.93% |
| 2000 Q1 | -229.41 Thousand USD | 0.0% |
| 1999 FY | -2.55 Million USD | -554.38% |
| 1998 FY | -390.37 Thousand USD | 75.83% |
| 1997 FY | -1.61 Million USD | -771.78% |
| 1996 FY | -185.28 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -77.59 Million USD | 73.297% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -55.121% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -331.863% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -4111.538% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 4123.45% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 78.627% |
| Agenus Inc. | 139.61 Million USD | 114.841% |
| Fortress Biotech, Inc. | 57.85 Million USD | 135.816% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -14359.61% |
| Novavax, Inc. | 639.93 Million USD | 103.238% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -3020.597% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 198.385% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -461.234% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 171.134% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 117.199% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 101.365% |
| AlloVir, Inc. | -398 Thousand USD | -5106.223% |
| Aptorum Group Limited | -1.11 Million USD | -1758.885% |
| Ardelyx, Inc. | 106.66 Million USD | 119.427% |
| Bicycle Therapeutics plc | -129.52 Million USD | 84.002% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 17367.305% |
| Chimerix, Inc. | 324 Thousand USD | 6495.298% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 33.518% |
| CRISPR Therapeutics AG | 240.95 Million USD | 108.599% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 363.255% |
| Precision BioSciences, Inc. | 40.47 Million USD | 151.198% |
| Dyadic International, Inc. | 922.95 Thousand USD | 2345.041% |
| Elevation Oncology, Inc. | -39 Thousand USD | -53030.169% |
| Fortress Biotech, Inc. | 57.85 Million USD | 135.816% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Alkermes plc | 1.37 Billion USD | 101.507% |
| Immix Biopharma, Inc. | -5468.00 USD | -378845.977% |
| Innoviva, Inc. | 261.06 Million USD | 107.937% |
| IO Biotech, Inc. | -756 Thousand USD | -2640.842% |
| Jaguar Health, Inc. | 7.72 Million USD | 368.265% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 117.303% |
| ContextLogic Inc. | 59 Million USD | 135.12% |
| AbCellera Biologics Inc. | 38.02 Million USD | 154.492% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -11751.07% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -37574.12% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 108.607% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -3831.834% |
| MEI Pharma, Inc. | 49.32 Million USD | 142.007% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 2683.637% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 171.316% |
| NextCure, Inc. | -3.68 Million USD | -462.453% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 224.997% |
| ChromaDex Corporation | 50.78 Million USD | 140.805% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 80.475% |
| Incyte Corporation | 3.44 Billion USD | 100.602% |
| Opthea Limited | 21.72 Thousand USD | 95499.475% |
| MiMedx Group, Inc. | 266.84 Million USD | 107.765% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -46792.292% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 196.174% |
| Psyence Biomedical Ltd. | -240.00 USD | -8633552.5% |
| Vaxcyte, Inc. | -75 Million USD | 72.372% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -36045.494% |
| Pharming Group N.V. | 220.1 Million USD | 109.414% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 2153.594% |
| Onconetix, Inc. | -1.12 Million USD | -1738.308% |
| Acelyrin, Inc. | -115 Thousand USD | -17918.057% |
| PureTech Health plc | -1.6 Million USD | -1192.624% |
| Pyxis Oncology, Inc. | -2 Million USD | -936.038% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 88.578% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -3909.855% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -17387.207% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 118.876% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 208.81% |
| Seer, Inc. | 7.02 Million USD | 394.874% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 54.284% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 5.759% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -206056.263% |
| Summit Therapeutics Inc. | -2.05 Million USD | -910.769% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -3528.856% |
| Senti Biosciences, Inc. | -2.68 Million USD | -672.298% |
| ImmuCell Corporation | 4.39 Million USD | 571.325% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 78.903% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 55.762% |
| Precigen, Inc. | 106 Thousand USD | 19647.892% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -414315.32% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 28.47% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 611.498% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 115.318% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -425.635% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 170.51% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 573.293% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 4277.574% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 4986.973% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -25169.227% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 119.905% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 78.891% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -8831.365% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 3502.425% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 106.606% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 905.003% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -40737.142% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -191.924% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -4266.449% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -199138.135% |
| Soligenix, Inc. | 97.31 Thousand USD | 21393.344% |
| Century Therapeutics, Inc. | -10.8 Million USD | -91.699% |
| Kura Oncology, Inc. | -849 Thousand USD | -2340.608% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 69.121% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -13995.759% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 120.922% |
| Autolus Therapeutics plc | -4.86 Million USD | -325.74% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 150.067% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -12233.789% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 121.875% |
| GRI Bio, Inc. | 10.84 Million USD | 291.133% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 915.783% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -138.526% |
| IGM Biosciences, Inc. | -211.66 Million USD | 90.21% |
| INmune Bio, Inc. | 155 Thousand USD | 13468.236% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 133.454% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -1275.615% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -3095.41% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -70682.148% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 5254.419% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -938.115% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -6520.053% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 121.936% |
| Verastem, Inc. | -62 Thousand USD | -33320.59% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 950.955% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -7838.991% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 784.531% |
| Histogen Inc. | 3.76 Million USD | 649.768% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 3696.238% |
| Surrozen, Inc. | -27.23 Million USD | 23.905% |
| Organovo Holdings, Inc. | -5.38 Million USD | -284.501% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -1619.737% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 19.208% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 203.335% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -1046403.333% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 441.565% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -30766.166% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 113.386% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 14311.774% |
| Apollomics, Inc. | 127 Thousand USD | 16415.564% |
| Amarin Corporation plc | 165.54 Million USD | 112.517% |
| Mesoblast Limited | -9.81 Million USD | -111.113% |
| Turnstone Biologics Corp. | 16.5 Million USD | 225.535% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 81.246% |
| Synaptogenix, Inc. | -6347.00 USD | -326365.511% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -40528.953% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 112.841% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 101.179% |
| Better Therapeutics, Inc. | -2.72 Million USD | -659.281% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 81.526% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 106.129% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -181533.643% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -231.003% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -1770.105% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 383.148% |
| Insmed Incorporated | 239.63 Million USD | 108.647% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 679.116% |
| OmniAb, Inc. | 14.66 Million USD | 241.275% |
| Alector, Inc. | -95.05 Million USD | 78.201% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 116.495% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 52.326% |
| Zai Lab Limited | 170.9 Million USD | 112.124% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 125.307% |
| Aura Biosciences, Inc. | -1.29 Million USD | -1500.059% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 16039.051% |
| Immunic, Inc. | -111 Thousand USD | -18567.357% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 230.697% |
| Veracyte, Inc. | 248.14 Million USD | 108.35% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.704% |
| FibroGen, Inc. | 128.9 Million USD | 116.075% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -3673794.681% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -77.603% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 100.61% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 5426.675% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 105.831% |
| TG Therapeutics, Inc. | 219.1 Million USD | 109.457% |
| Galecto, Inc. | -830 Thousand USD | -2396.478% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -1396.084% |
| Fortrea Holdings Inc. | 424 Million USD | 104.887% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 75.953% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -3554.456% |
| XBiotech Inc. | -1.74 Million USD | -1088.117% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -1770.105% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 55.411% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 72.568% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 128.229% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 223.316% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 105.326% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 58.264% |
| Vaxxinity, Inc. | -2.23 Million USD | -827.519% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 106.341% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -82.984% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 184.744% |
| NexImmune, Inc. | -1.02 Million USD | -1921.593% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 383817.889% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -191.609% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.183% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -30906.578% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -483.519% |
| Ainos, Inc. | -253.73 Thousand USD | -8066.366% |
| Pluri Inc. | 322 Thousand USD | 6535.02% |
| Prothena Corporation plc | -129.2 Million USD | 83.962% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 141.093% |
| Celularity Inc. | 6.75 Million USD | 406.747% |
| Rallybio Corporation | -150 Thousand USD | -13713.844% |
| Cue Biopharma, Inc. | -32.6 Million USD | 36.453% |
| MeiraGTx Holdings plc | 287 Thousand USD | 7319.779% |
| Omeros Corporation | -69.77 Million USD | 70.305% |
| Humacyte, Inc. | -76.55 Million USD | 72.932% |
| Immunocore Holdings plc | 248.39 Million USD | 108.342% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -36.599% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 133.216% |
| Blueprint Medicines Corporation | 236.58 Million USD | 108.758% |
| CalciMedica, Inc. | -58 Thousand USD | -35625.459% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -1353.069% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -628.578% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 32.866% |
| Pulmatrix, Inc. | -8.22 Million USD | -152.077% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -1671.006% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -5093.174% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 94.804% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 846.537% |
| Cytokinetics, Incorporated | -322.59 Million USD | 93.577% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 2503.508% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -5976.471% |
| Vor Biopharma Inc. | -3.49 Million USD | -493.378% |
| Roivant Sciences Ltd. | 109.23 Million USD | 118.969% |
| Evogene Ltd. | 1.39 Million USD | 1581.113% |
| ProKidney Corp. | -3.16 Million USD | -553.858% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 52.813% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 402.184% |
| CorMedix Inc. | -205.56 Thousand USD | -9980.057% |
| BioLineRx Ltd. | 1.1 Million USD | 1970.105% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 73.661% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -62690.2% |
| Atai Life Sciences N.V. | -5000.00 USD | -414315.32% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -16903.886% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -21484.131% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -1391.776% |
| Sagimet Biosciences Inc. | 2 Million USD | 1136.038% |
| MediciNova, Inc. | 979.7 Thousand USD | 2215.001% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 75.426% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -21813.982% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 108.474% |
| Biomea Fusion, Inc. | -4.2 Million USD | -393.234% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 102.375% |
| Mereo BioPharma Group plc | 7.42 Million USD | 379.03% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -6584.118% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -172573.05% |
| Absci Corporation | -41.84 Million USD | 50.487% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -414315.32% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 72.869% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -741.965% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 109.695% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -2101.994% |
| Allakos Inc. | -6.14 Million USD | -237.417% |
| Imunon, Inc. | -720 Thousand USD | -2777.864% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 69.968% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 104.354% |
| BioAtla, Inc. | -103.73 Million USD | 80.025% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -181533.643% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -11540.88% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 91.467% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -6562.626% |
| XOMA Corporation | 3.86 Million USD | 636.668% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 70.435% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 240.062% |
| aTyr Pharma, Inc. | -2.38 Million USD | -767.704% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 266.298% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -71350.917% |
| Viridian Therapeutics, Inc. | -1 Million USD | -1955.632% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 159390607.692% |
| Akari Therapeutics, Plc | -4000.00 USD | -517919.15% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 103.253% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 10741.97% |
| UroGen Pharma Ltd. | 73.35 Million USD | 128.248% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 22.377% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 178573.437% |
| Orgenesis Inc. | -5.72 Million USD | -261.935% |
| Entera Bio Ltd. | -56 Thousand USD | -36901.368% |
| GH Research PLC | -315 Thousand USD | -6478.021% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -10863.368% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -3846.813% |
| Xencor, Inc. | -85.26 Million USD | 75.697% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -9276.888% |
| Replimune Group, Inc. | -2.65 Million USD | -680.443% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -1969.519% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 111.651% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 10741.97% |
| Portage Biotech Inc. | -54 Thousand USD | -38271.789% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -21813.982% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -5396.224% |
| OncoCyte Corporation | 413 Thousand USD | 5117.135% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -460873.66% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -9333578.378% |
| Purple Biotech Ltd. | -196 Thousand USD | -10471.819% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 331.052% |
| scPharmaceuticals Inc. | 9.78 Million USD | 311.825% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -98.381% |
| HilleVax, Inc. | -2.15 Million USD | -861.074% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -21261.614% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -138001.613% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -3001.911% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -89990.287% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -275950.151% |
| Savara Inc. | -44.26 Million USD | 53.186% |
| Curis, Inc. | 9.81 Million USD | 311.199% |
| Daré Bioscience, Inc. | 2.76 Million USD | 848.171% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -16504.774% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -1098.425% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -8988.055% |
| BeiGene, Ltd. | 2.07 Billion USD | 100.997% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -641.113% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 94.815% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 136.552% |
| Erasca, Inc. | -3.73 Million USD | -455.219% |
| bluebird bio, Inc. | -4.03 Million USD | -414.163% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -73331.023% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 101.088% |
| DBV Technologies S.A. | 15.72 Million USD | 231.744% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -73331.023% |
| Moderna, Inc. | 2.15 Billion USD | 100.962% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -2164.565% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 358.815% |
| Molecular Templates, Inc. | 50.39 Million USD | 141.117% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -3765.815% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 115.488% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -233.024% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 47.333% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 81.354% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -477.502% |
| MacroGenics, Inc. | 50.52 Million USD | 141.009% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -239.796% |
| Prime Medicine, Inc. | -147.9 Million USD | 85.99% |
| Aditxt, Inc. | -111.66 Thousand USD | -18457.018% |
| Adagene Inc. | 18.11 Million USD | 214.407% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 4346.059% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 114.779% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 113.128% |
| SciSparc Ltd. | 2.19 Million USD | 1043.569% |
| Vericel Corporation | 135.57 Million USD | 115.284% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -82620.931% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -66780.014% |
| Generation Bio Co. | -73.91 Million USD | 71.965% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -4641.594% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 137.937% |
| Invivyd, Inc. | -2.02 Million USD | -921.734% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 93.112% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -19932.064% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 121.502% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 121.082% |
| ADMA Biologics, Inc. | 88.21 Million USD | 123.488% |
| Clene Inc. | 533 Thousand USD | 3987.573% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 185.946% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -2065.179% |
| GeoVax Labs, Inc. | -20.72 Million USD | -0.0% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 1142.292% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -10563.438% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 141.604% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -192.171% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -2378.561% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 124.841% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 28441.129% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 138.977% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 88.036% |
| Trevena, Inc. | 1.45 Million USD | 1524.108% |
| Surrozen, Inc. | -27.23 Million USD | 23.905% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -5769.905% |
| Cingulate Inc. | -582.91 Thousand USD | -3454.662% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -66741.181% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -5.187% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -273622.14% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -2251.96% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 103.044% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -1997.244% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -36676.767% |
| Kronos Bio, Inc. | 1.37 Million USD | 1610.26% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 61.389% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -6996.153% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -4143.328% |
| ImmunityBio, Inc. | -17.89 Million USD | -15.823% |
| Korro Bio, Inc. | -3.63 Million USD | -470.82% |
| Kineta, Inc. | 5.43 Million USD | 481.387% |
| BioVie Inc. | -229.37 Thousand USD | -8933.498% |
| Codexis, Inc. | 57.33 Million USD | 136.14% |
| Celularity Inc. | 6.75 Million USD | 406.747% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 616.341% |
| Celcuity Inc. | -142.77 Thousand USD | -14413.186% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 41058.225% |
| Cibus, Inc. | 1.42 Million USD | 1557.157% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -5440.312% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 9.591% |
| IN8bio, Inc. | -2.5 Million USD | -728.499% |
| Kodiak Sciences Inc. | -25.94 Million USD | 20.142% |
| Annexon, Inc. | -3.26 Million USD | -534.244% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -913.736% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 50.354% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 3337.62% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 102.662% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 111.98% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -990.567% |
| Arcellx, Inc. | 108.27 Million USD | 119.136% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 35.986% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 126.161% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 2.039% |
| Moolec Science SA | -143.3 Thousand USD | -14359.207% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 51.036% |
| Geron Corporation | -123.5 Million USD | 83.222% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 730.385% |
| Royalty Pharma plc | 1.79 Billion USD | 101.155% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 70.437% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -573564.618% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 9054.871% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 81.402% |
| Humacyte, Inc. | -76.55 Million USD | 72.932% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -2083.031% |
| 89bio, Inc. | -273 Thousand USD | -7490.024% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -1548.43% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -2343.487% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -16746.151% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 1951.722% |
| Notable Labs, Ltd. | 113 Thousand USD | 18436.961% |
| Liquidia Corporation | 14.6 Million USD | 241.923% |
| Mustang Bio, Inc. | -2.22 Million USD | -831.27% |
| Immunovant, Inc. | -231 Thousand USD | -8870.029% |
| Quantum-Si incorporated | 488 Thousand USD | 4346.059% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 62.705% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -68969.22% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 1212.823% |
| Acasti Pharma Inc. | -11 Thousand USD | -188270.6% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -10026.61% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -3095.41% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 87.63% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 1926.294% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -5338.521% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -958.262% |
| PepGen Inc. | -1.18 Million USD | -1650.065% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -16215.564% |
| United Therapeutics Corporation | 2.07 Billion USD | 101.001% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 9.504% |
| Solid Biosciences Inc. | -76.56 Million USD | 72.936% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -24990.837% |
| Immuneering Corporation | -764.13 Thousand USD | -2611.652% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 31370.02% |
| Belite Bio, Inc | -399 Thousand USD | -5093.174% |
| XOMA Corporation | 3.86 Million USD | 636.668% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -3.418% |
| Bionomics Limited | -434.44 Thousand USD | -4669.436% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -1829.308% |
| uniQure N.V. | 2.21 Million USD | 1035.475% |
| Cassava Sciences, Inc. | -89.42 Million USD | 76.828% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 77.494% |
| Forte Biosciences, Inc. | -9000.00 USD | -230130.733% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -2381.529% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -4641.594% |
| Altimmune, Inc. | -65.37 Million USD | 68.304% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 105.723% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -1829.308% |
| Compugen Ltd. | 31.45 Million USD | 165.874% |
| Peak Bio, Inc. | 367.76 Thousand USD | 5734.18% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 184.519% |
| Benitec Biopharma Inc. | 108 Thousand USD | 19285.894% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -26465.085% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -1622.424% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -1037.254% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -17312.408% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -1622.424% |
| Instil Bio, Inc. | -4.75 Million USD | -335.676% |
| argenx SE | 1.1 Billion USD | 101.869% |
| Immunome, Inc. | -8.9 Million USD | -132.635% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -996.337% |
| Verona Pharma plc | -679.62 Thousand USD | -2948.857% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -11740.438% |
| Shattuck Labs, Inc. | -2.38 Million USD | -768.795% |
| CervoMed Inc. | -1.29 Million USD | -1501.757% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -760.854% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -333.761% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 938.558% |
| Moolec Science SA | -143.3 Thousand USD | -14359.207% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -4978.246% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -675.615% |
| AnaptysBio, Inc. | 14.78 Million USD | 240.185% |
| Design Therapeutics, Inc. | -537 Thousand USD | -3758.616% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -4752.638% |
| NeurAxis, Inc. | 2.15 Million USD | 1060.761% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 1065.553% |
| Lumos Pharma, Inc. | 2 Million USD | 1132.425% |
| Achilles Therapeutics plc | -4.73 Million USD | -337.954% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -11740.438% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -19508.011% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 165.45% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 2503.508% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -1907.826% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 54.508% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 48287.828% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -2420.774% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -157376.562% |
| Palisade Bio, Inc. | 246 Thousand USD | 8523.076% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -62690.2% |
| Beam Therapeutics Inc. | -59.67 Million USD | 65.276% |
| Neurogene Inc. | -3.26 Million USD | -535.217% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 114.871% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 151.802% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -6876.689% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -414.541% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -116.608% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 247.165% |
| Athira Pharma, Inc. | -969 Thousand USD | -2038.366% |
| Vaccinex, Inc. | -16 Million USD | -29.472% |
| HCW Biologics Inc. | -574.82 Thousand USD | -3504.715% |
| XOMA Corporation | 3.86 Million USD | 636.668% |
| Nektar Therapeutics | 53.47 Million USD | 138.746% |
| Arvinas, Inc. | 71.8 Million USD | 128.859% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 75.173% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 66.992% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -6335.02% |
| Rezolute, Inc. | -36 Thousand USD | -57457.683% |
| Clene Inc. | 533 Thousand USD | 3987.573% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -1613666.822% |
| BeyondSpring Inc. | 1.75 Million USD | 1283.368% |
| Synlogic, Inc. | -1.92 Million USD | -976.963% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -55902.07% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -227.239% |
| Peak Bio, Inc. | 367.76 Thousand USD | 5734.18% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -9.269% |
| Krystal Biotech, Inc. | 47.6 Million USD | 143.526% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 114.686% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 512.354% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -700.271% |
| MannKind Corporation | 136.19 Million USD | 115.214% |
| Ikena Oncology, Inc. | -50.49 Million USD | 58.962% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 119.042% |
| Gossamer Bio, Inc. | -4.38 Million USD | -372.537% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -8122.526% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -414315.32% |
| Legend Biotech Corporation | 140.92 Million USD | 114.703% |
| Mural Oncology plc | -2.56 Million USD | -707.198% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -3660.575% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -20620.766% |
| Champions Oncology, Inc. | 20.75 Million USD | 199.84% |
| REGENXBIO Inc. | 53.02 Million USD | 139.074% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -286.801% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -10671.028% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -1096.349% |
| Vaxart, Inc. | -60.76 Million USD | 65.899% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -7785.214% |
| Cellectis S.A. | 18 Thousand USD | 115215.367% |
| Longeveron Inc. | 221 Thousand USD | 9475.912% |
| Repare Therapeutics Inc. | -80.07 Million USD | 74.122% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 101.896% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -1501.296% |
| Revolution Medicines, Inc. | -399.66 Million USD | 94.815% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -59102.189% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 42387.278% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.241% |
| Denali Therapeutics Inc. | -93.34 Million USD | 77.802% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -82620.931% |
| Veru Inc. | 7.56 Million USD | 373.869% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -13622.362% |
| Cingulate Inc. | -582.91 Thousand USD | -3454.662% |
| Passage Bio, Inc. | -3.72 Million USD | -456.86% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -171942.228% |
| Exicure, Inc. | -1.42 Million USD | -1356.133% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -5310.122% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 866.584% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -3941.696% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 130.415% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -13750.131% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 65.002% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 5399.429% |
| OmniAb, Inc. | 14.66 Million USD | 241.275% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 203.64% |
| Lipocine Inc. | -2.85 Million USD | -626.836% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -1024.295% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -263.204% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -1275.615% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 127.512% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -31778.102% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 124.581% |
| Ocugen, Inc. | -33.53 Million USD | 38.215% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -555.306% |
| Q32 Bio Inc. | 578 Thousand USD | 3684.908% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -7719.157% |
| Alumis Inc. Common Stock | -1.28 Million USD | -1513.767% |
| Equillium, Inc. | 35.95 Million USD | 157.625% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -1113.87% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 4238.533% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -501128.012% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -7900.296% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 5001.864% |
| Dominari Holdings Inc. | 2.03 Million USD | 1116.222% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -11193.755% |
| vTv Therapeutics Inc. | -13.59 Million USD | -52.415% |
| Bio-Techne Corporation | 773.07 Million USD | 102.68% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 219.642% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 104.497% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -1672.521% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 13.591% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 277.146% |
| Nkarta, Inc. | -5.86 Million USD | -253.054% |
| BioCardia, Inc. | -7.24 Million USD | -185.843% |
| Iterum Therapeutics plc | -1.75 Million USD | -1084.044% |